1 / 6

Cancer Immunotherapy Market: Growth, Demand and Key Players to 2026

Cancer immunotherapy is a type of cancer treatment that boosts the human bodys natural immune system to fight against the cancer cells.

MangeshPanhale
Télécharger la présentation

Cancer Immunotherapy Market: Growth, Demand and Key Players to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Nuclear Medicine Market Cancer Immunotherapy Market No. of Pages- 150 Global Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast, 2014-2022 Download Report Sample

  2. The global cancer immunotherapy market was valued at $45,471 million in 2015, and is projected to reach $117,114 million by 2022, growing at a CAGR of 14.5% from 2016 to 2022. The monoclonal antibodies segment held two-third share of the total market in 2015. Cancer immunotherapy, also known as biologic therapy, helps in cancer treatment by boosting the immunity of the body to fight against cancer. In this type of therapy antibodies and live viruses are introduced in the body that slows the growth of cancer cells. In addition, it also helps the immune system destroy the cancer cells. The major factors that drive the growth of this market include increase in incidence of cancers, growth in geriatric population, and rise in cancer R&D. However, shortage of skilled labor and lack of awareness about cancer immunotherapy is projected to restrain the market growth during the forecast period. The cancer immunotherapy market in this report is studied on the basis of technology, application, end-user, and region. Based on technology, the market is divided into monoclonal antibodies, cytokines & immunomodulators, and other technologies. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2244 Cancer Immunotherapy Market Download Report Sample

  3. Monoclonal antibodies held the largest share in 2015 owing to high usage of monoclonal antibodies for cancer immunotherapy as they exhibit different immunomodulatory properties and hence they can directly activate or inhibit the molecules of immune system. In addition, monoclonal antibodies also induce the antitumor immune response. By application, the cancer immunotherapy market is segmented as lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and other applications. The lung cancer market held the largest share in 2015 and is expected to lead the market during the analysis period owing to high incidence of lung cancer. Hospitals in end users held the largest market share of cancer immunotherapy market in 2015, and is projected to show the highest growth rate during the analysis period due to the extensive use of cancer immunotherapy in the hospitals. Geographically, the global cancer immunotherapy market is analyzed by four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. North America was the highest revenue contributor in 2015. This is attributed to the ample amount of expenditure in healthcare, well-established healthcare system, and high incidence of cancer. However, Asia-Pacific region is projected to be grow with the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, and improvement in healthcare infrastructure. Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2244 Cancer Immunotherapy Market Download Report Sample

  4. The Major Key Players Are: • Amgen Inc. • Advaxis Inc. • Merck & Co., Inc. • Eli Lilly and Company • Bristol-Myers Squibb Company • Pfizer Inc. • Novartis AG • Bayer AG • Immunomedics Inc. • Astrazeneca plc. Cancer Immunotherapy Market Download Report Sample

  5. Key Findings of the Cancer Immunotherapy Market: • The monoclonal antibody accounted for the largest market share for technology segment in 2015 and is also estimated to grow at the highest CAGR of 15.0%. • By application, lung cancer held the highest market share and is anticipated to lead the market during the analysis period. • The U.S. was the major shareholder in the North American cancer immunotherapy market, accounting for six-seventh share in 2015. • China is expected to show the highest growth rate during the analysis period for the Asia-Pacific cancer immunotherapy market. Cancer Immunotherapy Market Download Report Sample

  6. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Cancer Immunotherapy Market Download Report Sample

More Related